OncoCyte (NASDAQ:OCX) Receives New Coverage from Analysts at StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
StockNews.com started coverage on shares of OncoCyte (NASDAQ:OCX – Free Report) in a report released on Tuesday. The brokerage issued a sell rating on the stock. Other research analysts have also issued reports about the stock. Benchmark decreased their price objective on shares of OncoCyte from $9.00 to $5.00 and set a speculative buy rating […]
OncoCyte (NASDAQ:OCX – Get Free Report) had its price objective lowered by investment analysts at Piper Sandler from $3.50 to $3.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “neutral” rating on the stock. Piper Sandler’s target price suggests a potential downside of 10.18% from […]
OncoCyte (NASDAQ:OCX) Now Covered by StockNews com themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.